Skip to main content
Erschienen in: European Radiology 2/2022

12.08.2021 | Gastrointestinal

Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM)

verfasst von: Maria Antonietta Mazzei, Giulio Bagnacci, Francesco Gentili, Iacopo Capitoni, Gianni Mura, Daniele Marrelli, Roberto Petrioli, Luca Brunese, Salvatore Cappabianca, Marco Catarci, Maurizio Degiuli, Giovanni De Manzoni, Marco De Prizio, Annibale Donini, Uberto Fumagalli Romario, Luigi Funicelli, Andrea Laghi, Giuseppe Minetti, Paolo Morgagni, Enrico Petrella, Frida Pittiani, Stefano Rausei, Laura Romanini, Riccardo Rosati, Amato Antonio Stabile Ianora, Guido A. M. Tiberio, Luca Volterrani, Franco Roviello, Roberto Grassi

Erschienen in: European Radiology | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Written radiological report remains the most important means of communication between radiologist and referring medical/surgical doctor, even though CT reports are frequently just descriptive, unclear, and unstructured. The Italian Society of Medical and Interventional Radiology (SIRM) and the Italian Research Group for Gastric Cancer (GIRCG) promoted a critical shared discussion between 10 skilled radiologists and 10 surgical oncologists, by means of multi-round consensus-building Delphi survey, to develop a structured reporting template for CT of GC patients.

Methods

Twenty-four items were organized according to the broad categories of a structured report as suggested by the European Society of Radiology (clinical referral, technique, findings, conclusion, and advice) and grouped into three “CT report sections” depending on the diagnostic phase of the radiological assessment for the oncologic patient (staging, restaging, and follow-up).

Results

In the final round, 23 out of 24 items obtained agreement ( ≥ 8) and consensus ( ≤ 2) and 19 out 24 items obtained a good stability (p > 0.05).

Conclusions

The structured report obtained, shared by surgical and medical oncologists and radiologists, allows an appropriate, clearer, and focused CT report essential to high-quality patient care in GC, avoiding the exclusion of key radiological information useful for multidisciplinary decision-making.

Key Points

• Imaging represents the cornerstone for tailored treatment in GC patients.
• CT-structured radiology report in GC patients is useful for multidisciplinary decision making.
Literatur
1.
Zurück zum Zitat Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F (2020) Gastric cancer. Lancet 396:635–648PubMedCrossRef Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F (2020) Gastric cancer. Lancet 396:635–648PubMedCrossRef
2.
Zurück zum Zitat Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513:202–209CrossRef Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513:202–209CrossRef
3.
Zurück zum Zitat Smyth EC, Verheij M, Allum W et al (2016) Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 27(suppl 5):v38–v49PubMedCrossRef Smyth EC, Verheij M, Allum W et al (2016) Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 27(suppl 5):v38–v49PubMedCrossRef
4.
Zurück zum Zitat Allum W, Lordick F, Alsina M et al (2018) ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer. Crit Rev Oncol Hematol 122:179–193PubMedCrossRef Allum W, Lordick F, Alsina M et al (2018) ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer. Crit Rev Oncol Hematol 122:179–193PubMedCrossRef
5.
Zurück zum Zitat Millor M, Bartolomé P, Pons MJ et al (2019) Whole-body computed tomography: a new point of view in a hospital check-up unit? Our experience in 6516 patients. Radiol Med 124:1199–1211PubMedCrossRef Millor M, Bartolomé P, Pons MJ et al (2019) Whole-body computed tomography: a new point of view in a hospital check-up unit? Our experience in 6516 patients. Radiol Med 124:1199–1211PubMedCrossRef
6.
Zurück zum Zitat Petralia G, Padhani AR, Pricolo P et al (2019) Whole-body magnetic resonance imaging (WB-MRI) in oncology: recommendations and key uses. Radiol Med 124:218–233PubMedCrossRef Petralia G, Padhani AR, Pricolo P et al (2019) Whole-body magnetic resonance imaging (WB-MRI) in oncology: recommendations and key uses. Radiol Med 124:218–233PubMedCrossRef
7.
Zurück zum Zitat Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T et al (2015) Endoscopic submucosal dissection: European society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy 47:829–854PubMedCrossRef Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T et al (2015) Endoscopic submucosal dissection: European society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy 47:829–854PubMedCrossRef
8.
Zurück zum Zitat Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20PubMedCrossRef Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20PubMedCrossRef
9.
Zurück zum Zitat Schuhmacher C, Gretschel S, Lordick F et al (2010) Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. J Clin Oncol 28:5210–5218PubMedPubMedCentralCrossRef Schuhmacher C, Gretschel S, Lordick F et al (2010) Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. J Clin Oncol 28:5210–5218PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Ychou M, Boige V, Pignon JP et al (2011) Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 29:1715–1721PubMedCrossRef Ychou M, Boige V, Pignon JP et al (2011) Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 29:1715–1721PubMedCrossRef
11.
Zurück zum Zitat Kang Y-K, Yook JH, Park Y-K et al (2019) Phase III randomized study of neoadjuvant chemotherapy (CT) with docetaxel(D), oxaliplatin(O) and S-1(S) (DOS) followed by surgery and adjuvant S-1, vs surgery and adjuvant S-1, for resectable advanced gastric cancer (GC) (PRODIGY). Ann Oncol. https://doi.org/10.1093/annonc/mdz394.032 Kang Y-K, Yook JH, Park Y-K et al (2019) Phase III randomized study of neoadjuvant chemotherapy (CT) with docetaxel(D), oxaliplatin(O) and S-1(S) (DOS) followed by surgery and adjuvant S-1, vs surgery and adjuvant S-1, for resectable advanced gastric cancer (GC) (PRODIGY). Ann Oncol. https://​doi.​org/​10.​1093/​annonc/​mdz394.​032
12.
Zurück zum Zitat Ji J, Shen L, Li Z et al (2019) Perioperative chemotherapy of oxaliplatin combined with s-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: a randomized phase III trial (RESOLVE Trial). Ann Oncol. https://doi.org/10.1093/annonc/mdz394.033 Ji J, Shen L, Li Z et al (2019) Perioperative chemotherapy of oxaliplatin combined with s-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: a randomized phase III trial (RESOLVE Trial). Ann Oncol. https://​doi.​org/​10.​1093/​annonc/​mdz394.​033
13.
Zurück zum Zitat Al-Batran SE, Homann N, Pauligk C et al (2019) Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet 393:1948–1957PubMedCrossRef Al-Batran SE, Homann N, Pauligk C et al (2019) Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet 393:1948–1957PubMedCrossRef
14.
Zurück zum Zitat De Manzoni G, Marrelli D, Baiocchi GL et al (2017) The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015. Gastric Cancer 20:20–30PubMedCrossRef De Manzoni G, Marrelli D, Baiocchi GL et al (2017) The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015. Gastric Cancer 20:20–30PubMedCrossRef
15.
Zurück zum Zitat Zhu Z, Gong Y, Xu H (2020) Neoadjuvant therapy strategies for advanced gastric cancer: current innovations and future challenges. Chronic Dis Transl Med 6:147–157PubMedPubMedCentral Zhu Z, Gong Y, Xu H (2020) Neoadjuvant therapy strategies for advanced gastric cancer: current innovations and future challenges. Chronic Dis Transl Med 6:147–157PubMedPubMedCentral
16.
Zurück zum Zitat Sun W, Yan L (2016) Gastric cancer: current and evolving treatment landscape. Chin J Cancer 31(1):35–83 Sun W, Yan L (2016) Gastric cancer: current and evolving treatment landscape. Chin J Cancer 31(1):35–83
17.
Zurück zum Zitat Bonnot PE, Piessen G, Kepenekian V et al (2019) Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol 37:2028–2040PubMedCrossRef Bonnot PE, Piessen G, Kepenekian V et al (2019) Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol 37:2028–2040PubMedCrossRef
18.
Zurück zum Zitat Zhang HW, Yang JJ, Zheng JY, Sun L, Yang XW, Li GC (2019) Postoperative intraperitoneal hyperthermic perfusion improve survival for advanced gastric cancer. Medicine (Baltimore) 98:e16598CrossRef Zhang HW, Yang JJ, Zheng JY, Sun L, Yang XW, Li GC (2019) Postoperative intraperitoneal hyperthermic perfusion improve survival for advanced gastric cancer. Medicine (Baltimore) 98:e16598CrossRef
19.
Zurück zum Zitat Beom SH, Choi YY, Baek SE et al (2018) Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy. BMC Cancer 18:1116PubMedPubMedCentralCrossRef Beom SH, Choi YY, Baek SE et al (2018) Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy. BMC Cancer 18:1116PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Solaini L, Ministrini S, Bencivenga M et al (2019) Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study. Gastric Cancer 22:1285–1293PubMedCrossRef Solaini L, Ministrini S, Bencivenga M et al (2019) Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study. Gastric Cancer 22:1285–1293PubMedCrossRef
22.
Zurück zum Zitat Marrelli D, Mazzei MA, Pedrazzani C et al (2011) High accuracy of multislices computed tomography (MSCT) for para-aortic lymph node metastases from gastric cancer: a prospective single-center study. Ann Surg Oncol 18(8):2265–2272PubMedCrossRef Marrelli D, Mazzei MA, Pedrazzani C et al (2011) High accuracy of multislices computed tomography (MSCT) for para-aortic lymph node metastases from gastric cancer: a prospective single-center study. Ann Surg Oncol 18(8):2265–2272PubMedCrossRef
23.
Zurück zum Zitat Mazzei MA, Cioffi Squitieri N, Vindigni C et al (2020) Gastrointestinal stromal tumors (GIST): a proposal of a “CT-based predictive model of Miettinen index” in predicting the risk of malignancy. Abdom Radiol 45(10):2989–2996CrossRef Mazzei MA, Cioffi Squitieri N, Vindigni C et al (2020) Gastrointestinal stromal tumors (GIST): a proposal of a “CT-based predictive model of Miettinen index” in predicting the risk of malignancy. Abdom Radiol 45(10):2989–2996CrossRef
24.
Zurück zum Zitat Larson DB (2018) Strategies for implementing a standardized structured radiology reporting program. Radiographics. 38:1705–1716PubMedCrossRef Larson DB (2018) Strategies for implementing a standardized structured radiology reporting program. Radiographics. 38:1705–1716PubMedCrossRef
25.
Zurück zum Zitat Amin MB, Edge S, Greene F, Byrd DR et al (2018) AJCC cancer staging manual, 8th edn. Springer International Publishing Amin MB, Edge S, Greene F, Byrd DR et al (2018) AJCC cancer staging manual, 8th edn. Springer International Publishing
26.
Zurück zum Zitat Good practice for radiological reporting (2011) Guidelines from the European Society of Radiology (ESR). Insights Imag 2:93–96CrossRef Good practice for radiological reporting (2011) Guidelines from the European Society of Radiology (ESR). Insights Imag 2:93–96CrossRef
27.
Zurück zum Zitat Trevelyan EG, Robinson N (2015) Delphi methodology in health research: how to do it? Eur J Integr Med 7:423–428CrossRef Trevelyan EG, Robinson N (2015) Delphi methodology in health research: how to do it? Eur J Integr Med 7:423–428CrossRef
28.
Zurück zum Zitat Mazzei MA, Bagnacci G, Gentili F et al (2018) Gastric cancer maximum tumour diameter reduction rate at CT examination as a radiological index for predicting histopathological regression after neoadjuvant treatment: a multicentre GIRCG study. Gastroenterol Res Pract 2018:1794524PubMedPubMedCentralCrossRef Mazzei MA, Bagnacci G, Gentili F et al (2018) Gastric cancer maximum tumour diameter reduction rate at CT examination as a radiological index for predicting histopathological regression after neoadjuvant treatment: a multicentre GIRCG study. Gastroenterol Res Pract 2018:1794524PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Mazzei MA, Nardone V, Di Giacomo L et al (2018) The role of delta radiomics in gastric cancer. Quant Imag Med Surg 8(7):719–721CrossRef Mazzei MA, Nardone V, Di Giacomo L et al (2018) The role of delta radiomics in gastric cancer. Quant Imag Med Surg 8(7):719–721CrossRef
30.
Zurück zum Zitat Ma M, Di Giacomo L, Bagnacci G et al (2021) Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer—a multicenter study of GIRCG (Italian Research Group for Gastric Cancer). Quant Imaging Med Surg. 11(6):2376–2387 Ma M, Di Giacomo L, Bagnacci G et al (2021) Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer—a multicenter study of GIRCG (Italian Research Group for Gastric Cancer). Quant Imaging Med Surg. 11(6):2376–2387
31.
Zurück zum Zitat Messina C, Bignone R, Bruno A et al (2020) Diffusion-weighted imaging in oncology: an update. Cancers (Basel) 12(6):1493CrossRef Messina C, Bignone R, Bruno A et al (2020) Diffusion-weighted imaging in oncology: an update. Cancers (Basel) 12(6):1493CrossRef
32.
Zurück zum Zitat Kane B, Luz S, O'Briain DS, McDermott R (2007) Multidisciplinary team meetings and their impact on workflow in radiology and pathology departments. BMC Med 13:5–15 Kane B, Luz S, O'Briain DS, McDermott R (2007) Multidisciplinary team meetings and their impact on workflow in radiology and pathology departments. BMC Med 13:5–15
33.
Zurück zum Zitat Shi B, Lin H, Zhang M, Lu W, Qu Y, Zhang H (2018) Gene regulation and targeted therapy in gastric cancer peritoneal metastasis: radiological findings from dual energy CT and PET/CT. J Vis Exp 22(131):56526 Shi B, Lin H, Zhang M, Lu W, Qu Y, Zhang H (2018) Gene regulation and targeted therapy in gastric cancer peritoneal metastasis: radiological findings from dual energy CT and PET/CT. J Vis Exp 22(131):56526
34.
Zurück zum Zitat Darras KE, Clark SJ, Kang H et al (2019) Virtual monoenergetic reconstruction of contrast-enhanced CT scans of the abdomen and pelvis at 40 keV improves the detection of peritoneal metastatic deposits. Abdom Radiol (NY) 44(2):422–428CrossRef Darras KE, Clark SJ, Kang H et al (2019) Virtual monoenergetic reconstruction of contrast-enhanced CT scans of the abdomen and pelvis at 40 keV improves the detection of peritoneal metastatic deposits. Abdom Radiol (NY) 44(2):422–428CrossRef
35.
Zurück zum Zitat Volterrani L, Gentili F, Fausto A et al (2020) Dual-energy CT for locoregional staging of breast cancer: preliminary results. AJR Am J Roentgenol 214(3):707–714PubMedCrossRef Volterrani L, Gentili F, Fausto A et al (2020) Dual-energy CT for locoregional staging of breast cancer: preliminary results. AJR Am J Roentgenol 214(3):707–714PubMedCrossRef
36.
Zurück zum Zitat Gentili F, Guerrini S, Mazzei FG et al (2020) Dual energy CT in gland tumors: a comprehensive narrative review and differential diagnosis. Gland Surg 9(6):2269–2282PubMedPubMedCentralCrossRef Gentili F, Guerrini S, Mazzei FG et al (2020) Dual energy CT in gland tumors: a comprehensive narrative review and differential diagnosis. Gland Surg 9(6):2269–2282PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Agostini A, Borgheresi A, Mari A et al (2019) Dual-energy CT: theoretical principles and clinical applications. Radiol Med 124(12):1281–1295PubMedCrossRef Agostini A, Borgheresi A, Mari A et al (2019) Dual-energy CT: theoretical principles and clinical applications. Radiol Med 124(12):1281–1295PubMedCrossRef
38.
Zurück zum Zitat Cicero G, Ascenti G, Albrecht MH et al (2020) Extra-abdominal dual-energy CT applications: a comprehensive overview. Radiol Med 125(4):384–397PubMedCrossRef Cicero G, Ascenti G, Albrecht MH et al (2020) Extra-abdominal dual-energy CT applications: a comprehensive overview. Radiol Med 125(4):384–397PubMedCrossRef
39.
Zurück zum Zitat Cornacchia S, Errico R, Balzano RF et al (2019) Medical radiological procedures: which information would be chosen for the report? Radiol Med 124(8):783–793PubMedCrossRef Cornacchia S, Errico R, Balzano RF et al (2019) Medical radiological procedures: which information would be chosen for the report? Radiol Med 124(8):783–793PubMedCrossRef
40.
Zurück zum Zitat Ross T, Pawa N (2020) The multi-disciplinary team - who is liable when things go wrong? Eur J Surg Oncol 46(1):95–97PubMedCrossRef Ross T, Pawa N (2020) The multi-disciplinary team - who is liable when things go wrong? Eur J Surg Oncol 46(1):95–97PubMedCrossRef
41.
Zurück zum Zitat Sidhom MA, Poulsen MG (2006) Multidisciplinary care in oncology: medicolegal implications of group decisions. Lancet Oncol 7(11):951–954PubMedCrossRef Sidhom MA, Poulsen MG (2006) Multidisciplinary care in oncology: medicolegal implications of group decisions. Lancet Oncol 7(11):951–954PubMedCrossRef
42.
Zurück zum Zitat Neri E, Gabelloni M, Bäuerle T et al (2021) Involvement of radiologists in oncologic multidisciplinary team meetings: an international survey by the European Society of Oncologic Imaging. Eur Radiol 31:983–991PubMedCrossRef Neri E, Gabelloni M, Bäuerle T et al (2021) Involvement of radiologists in oncologic multidisciplinary team meetings: an international survey by the European Society of Oncologic Imaging. Eur Radiol 31:983–991PubMedCrossRef
43.
Zurück zum Zitat Japanese Gastric Cancer Association (2021) Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer 24:1–21CrossRef Japanese Gastric Cancer Association (2021) Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer 24:1–21CrossRef
44.
Zurück zum Zitat Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247PubMedCrossRef Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247PubMedCrossRef
Metadaten
Titel
Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM)
verfasst von
Maria Antonietta Mazzei
Giulio Bagnacci
Francesco Gentili
Iacopo Capitoni
Gianni Mura
Daniele Marrelli
Roberto Petrioli
Luca Brunese
Salvatore Cappabianca
Marco Catarci
Maurizio Degiuli
Giovanni De Manzoni
Marco De Prizio
Annibale Donini
Uberto Fumagalli Romario
Luigi Funicelli
Andrea Laghi
Giuseppe Minetti
Paolo Morgagni
Enrico Petrella
Frida Pittiani
Stefano Rausei
Laura Romanini
Riccardo Rosati
Amato Antonio Stabile Ianora
Guido A. M. Tiberio
Luca Volterrani
Franco Roviello
Roberto Grassi
Publikationsdatum
12.08.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 2/2022
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-021-08205-0

Weitere Artikel der Ausgabe 2/2022

European Radiology 2/2022 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.